A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Andrea Cortegiani, Giulia Ingoglia, Mariachiara Ippolito, Antonino Giarratano, Sharon Einav
Journal of Critical Care, doi:10.1016/j.jcrc.2020.03.005
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Authors' contribution AC conceived the content, retrieved the data, wrote the manuscript and approved the final version. MI retrieved the data, wrote the manuscript and approved the final version. GI retrieved the data, wrote the manuscript and approved the final version. AG conceived the content, helped in data extraction, revised the manuscript critically and approved the final version. SE conceived the content, helped in data extraction, wrote the manuscript and approved the final version.
Appendix A. Supplementary data Supplementary data to this article can be found online at https://doi. org/10.1016/j.jcrc.2020.03.005.
References
Colson, Rolain, Raoult, Chloroquine for the 2019 novel coronavirus SARS-CoV-2, Int J Antimicrob Agents
Gao, Tian, Yang, Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends,
doi:10.5582/bst.2020.01047Guan, Ni, Hu, Liang, Ou et al., Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med,
doi:10.1056/NEJMoa2002032Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Lenk, Duttge, Ethical and legal framework and regulation for off-label use: European perspective, Ther Clin Risk Manag
Savarino, Boelaert, Cassone, Majori, Cauda, Effects of chloroquine on viral infections: an old drug against today's diseases?, Lancet Infect Dis
Wang, Cao, Zhang, Yang, Liu et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res,
doi:10.1038/s4142202002820Wang, Hu, Hu, Zhu, Liu et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in,
doi:10.1001/jama.2020.1585Yang, Yu, Xu, Shu, Xia et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med,
doi:10.1016/S2213-2600(20)30079-5{ 'indexed': {'date-parts': [[2024, 5, 13]], 'date-time': '2024-05-13T12:40:42Z', 'timestamp': 1715604042255},
'reference-count': 11,
'publisher': 'Elsevier BV',
'license': [ { 'start': { 'date-parts': [[2020, 6, 1]],
'date-time': '2020-06-01T00:00:00Z',
'timestamp': 1590969600000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}],
'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au',
'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'],
'crossmark-restriction': True},
'published-print': {'date-parts': [[2020, 6]]},
'DOI': '10.1016/j.jcrc.2020.03.005',
'type': 'journal-article',
'created': {'date-parts': [[2020, 3, 10]], 'date-time': '2020-03-10T16:37:37Z', 'timestamp': 1583858257000},
'page': '279-283',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 659,
'title': 'A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19',
'prefix': '10.1016',
'volume': '57',
'author': [ {'given': 'Andrea', 'family': 'Cortegiani', 'sequence': 'first', 'affiliation': []},
{'given': 'Giulia', 'family': 'Ingoglia', 'sequence': 'additional', 'affiliation': []},
{'given': 'Mariachiara', 'family': 'Ippolito', 'sequence': 'additional', 'affiliation': []},
{'given': 'Antonino', 'family': 'Giarratano', 'sequence': 'additional', 'affiliation': []},
{'given': 'Sharon', 'family': 'Einav', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'reference': [ { 'key': '10.1016/j.jcrc.2020.03.005_bb0005',
'doi-asserted-by': 'crossref',
'DOI': '10.1001/jama.2020.2648',
'article-title': 'Characteristics of and important lessons from the coronavirus disease '
'2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases '
'from the Chinese Center for Disease Control and Prevention',
'author': 'Wu',
'year': '2020',
'journal-title': 'Jama'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0010',
'doi-asserted-by': 'crossref',
'first-page': '722',
'DOI': '10.1016/S1473-3099(03)00806-5',
'article-title': 'Effects of chloroquine on viral infections: an old drug against today’s '
'diseases?',
'volume': '3',
'author': 'Savarino',
'year': '2003',
'journal-title': 'Lancet Infect Dis'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0015',
'doi-asserted-by': 'crossref',
'first-page': '105923',
'DOI': '10.1016/j.ijantimicag.2020.105923',
'article-title': 'Chloroquine for the 2019 novel coronavirus SARS-CoV-2',
'author': 'Colson',
'year': '2020',
'journal-title': 'Int J Antimicrob Agents'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0025',
'doi-asserted-by': 'crossref',
'DOI': '10.5582/bst.2020.01047',
'article-title': 'Breakthrough: chloroquine phosphate has shown apparent efficacy in '
'treatment of COVID-19 associated pneumonia in clinical studies',
'author': 'Gao',
'year': '2020',
'journal-title': 'Biosci Trends'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0030',
'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged '
'novel coronavirus (2019-nCoV) in vitro',
'author': 'Wang',
'year': '2020',
'journal-title': 'Cell Res'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0035',
'article-title': 'Expert consensus on chloroquine phosphate for the treatment of novel '
'coronavirus pneumonia',
'volume': '43',
'year': '2020',
'journal-title': 'Zhonghua Jie He He Hu Xi Za Zhi'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0060',
'doi-asserted-by': 'crossref',
'DOI': '10.1056/NEJMoa2002032',
'article-title': 'Clinical Characteristics of Coronavirus Disease 2019 in China',
'author': 'Guan',
'year': '2020',
'journal-title': 'N Engl J Med'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0065',
'doi-asserted-by': 'crossref',
'DOI': '10.1001/jama.2020.1585',
'article-title': 'Clinical characteristics of 138 hospitalized patients with 2019 novel '
'coronavirus-infected pneumonia in Wuhan, China',
'author': 'Wang',
'year': '2020',
'journal-title': 'Jama'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0070',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/S2213-2600(20)30079-5',
'article-title': 'Clinical course and outcomes of critically ill patients with SARS-CoV-2 '
'pneumonia in Wuhan, China: a single-centered, retrospective, '
'observational study',
'author': 'Yang',
'year': '2020',
'journal-title': 'Lancet Respir Med'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0075',
'doi-asserted-by': 'crossref',
'first-page': '497',
'DOI': '10.1016/S0140-6736(20)30183-5',
'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in '
'Wuhan, China',
'volume': '395',
'author': 'Huang',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.jcrc.2020.03.005_bb0090',
'doi-asserted-by': 'crossref',
'first-page': '537',
'DOI': '10.2147/TCRM.S40232',
'article-title': 'Ethical and legal framework and regulation for off-label use: European '
'perspective',
'volume': '10',
'author': 'Lenk',
'year': '2014',
'journal-title': 'Ther Clin Risk Manag'}],
'container-title': 'Journal of Critical Care',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0883944120303907?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S0883944120303907?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2020, 6, 10]],
'date-time': '2020-06-10T14:30:25Z',
'timestamp': 1591799425000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0883944120303907'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 6]]},
'references-count': 11,
'alternative-id': ['S0883944120303907'],
'URL': 'http://dx.doi.org/10.1016/j.jcrc.2020.03.005',
'relation': {},
'ISSN': ['0883-9441'],
'subject': [],
'container-title-short': 'Journal of Critical Care',
'published': {'date-parts': [[2020, 6]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'A systematic review on the efficacy and safety of chloroquine for the treatment '
'of COVID-19',
'name': 'articletitle',
'label': 'Article Title'},
{'value': 'Journal of Critical Care', 'name': 'journaltitle', 'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.jcrc.2020.03.005',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2020 Elsevier Inc. All rights reserved.',
'name': 'copyright',
'label': 'Copyright'}]}
